Christian Wolfrum,Erick Carriera,Bettina Meissburger
申请号：
US14345597
公开号：
US20140343023A1
申请日:
2012.09.18
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to compounds of formula I, or a pharmaceutically acceptable salt thereof,for use in the treatment or prevention, suppression or amelioration of a disease mediated by the ROR gamma receptor in a subject in need thereof, in particular diabetes and diabetes-related disorders, specifically type II diabetes, methods of their production, as well as methods of treatment or prevention of such diseases.
